Our studies also identified agents that prevent ferroptotic death in cancer cells and neurons that would not be good candidates for cancer treatment (e.g., HIF PHD inhibitors, transglutaminase inhibitors, and the gene selective Sp1 inhibitor Mithramycin). Here, PDC is linked to cancer.